In the hypothesis that the increased collagen metabolism in the intestinal wall of patients affected by ulcerative colitis (UC) is reflected in the systemic circulation, we aimed the study to evaluate serum level of aminoterminal propeptide of type III procollagen (PIIINP) in peripheral and splanchnic circulation by a commercial radioimmunoassay of patients with different histories of disease.
Aminoterminal propeptide of type III procollagen as a new seromarker in ulcerative colitis / M. De Simone, U. Cioffi, M.M. Ciulla, G. Bolla, R. Marconato, F. Botti, A. Carrara, B. Oreggia, E. Contessini Avesani. - In: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. - ISSN 0077-8923. - 1072:(2006 Aug). ((Intervento presentato al convegno Inflammatory Bowel Disease Research Drives Clinics Genetics, Barrier Function, Immunologic & Microbial Pathways tenutosi a Münster, Germany nel 2005.
Aminoterminal propeptide of type III procollagen as a new seromarker in ulcerative colitis
M. De SimonePrimo
;U. CioffiSecondo
;M.M. Ciulla;G. Bolla;R. Marconato;F. Botti;A. Carrara;B. OreggiaPenultimo
;E. Contessini AvesaniUltimo
2006
Abstract
In the hypothesis that the increased collagen metabolism in the intestinal wall of patients affected by ulcerative colitis (UC) is reflected in the systemic circulation, we aimed the study to evaluate serum level of aminoterminal propeptide of type III procollagen (PIIINP) in peripheral and splanchnic circulation by a commercial radioimmunoassay of patients with different histories of disease.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
